Prabhudas Lilladher's research report on Marico
MRCO 4Q results displayed the impact of COVID lockdown and pantry stocking in Saffola even as VAHO and Parachute suffered. MRCO has extended several incentives to trade and expects strong growth in Saffola and gradual stabilization in Parachute and VAHO. Input costs and benign and provide a lever to MRCO to reduce prices and gain share from unorganized players. However, we believe that current momentum in Saffola is led by sustained pantry stocking by consumers and is unsustainable. We believe non-essential products like Parachute, VAHO and personal care will recover after a while and impact of lockdown will be visible in IBD for 1HFY21.
Outlook
We estimate 7.2% PAT CAGR over FY20-22 and 11.3% PAT growth in FY22. MRCO is currently trading at 31.1xFY22 EPS which reflects uncertainty over growth and limited new product success over the years. We value the stock at 35xFY22 EPS and arrive at target price of Rs318 (Rs329 based on 36xFY22 EPS earlier). Retain Hold.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
Read More
